Dr Behera speaks with ecancertv at ASCO 2016 about a new modality in radiotherapy for non-small cell lung cancer; using proton beam therapy in place of photon.
The increased targeting of proton therapy compared to current photon sources reduces damage to surrounding tissues, especially the heart, and increases tumour shrinkage, resulting in increased overall survival among patients.
Dr Behera acknowledges barriers to access of proton therapy, and highlights ongoing research into proton therapy to treat other diseases.
ecancer's filming at ASCO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.